Literature DB >> 21448560

Identical glycine substitution mutations in type VII collagen may underlie both dominant and recessive forms of dystrophic epidermolysis bullosa.

Noor Almaani1, Lu Liu, Patricia J C Dopping-Hepenstal, Joey E Lai-Cheong, Alvin Wong, Arti Nanda, Celia Moss, Anna E Martinéz, Jemima E Mellerio, John A McGrath.   

Abstract

Autosomal dominant and recessive forms of dystrophic epidermolysis bullosa (DEB) result from mutations in the type VII collagen gene (COL7A1). Although paradigms have emerged for genotype/phenotype correlation in DEB, some pathogenic mutations in COL7A1, notably glycine substitutions within the type VII collagen triple helix, may lead to diagnostic difficulties, since certain glycine substitutions can result in either dominant or recessive mutant alleles. Delineation of glycine substitution mutations into two discrete groups, however, is made difficult by observations that, for some particular glycine substitutions in type VII collagen, the same mutation can result in both dominant and recessive disease. In this report we describe four further glycine missense mutations: p.Gly1483Asp, p.Gly1770Ser, p.Gly2213Arg and p.Gly2369Ser, which can lead to either dominant or recessive DEB, and which result in a spectrum of clinical abnormalities. We also identify a further 30 new glycine substitution mutations that cause either dominant or recessive DEB, but not both. In screening the COL7A1 gene for mutations in individuals with DEB our data highlight that delineation of glycine substitutions in type VII collagen has important implications for genetic counselling.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21448560     DOI: 10.2340/00015555-1053

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  10 in total

1.  Probability of high-risk genetic matching with oocyte and semen donors: complete gene analysis or genotyping test?

Authors:  Marta Molina Romero; Alberto Yoldi Chaure; Miguel Gañán Parra; Purificación Navas Bastida; José Luis Del Pico Sánchez; Ángel Vaquero Argüelles; Paloma de la Fuente Vaquero; Juan Pablo Ramírez López; José Antonio Castilla Alcalá
Journal:  J Assist Reprod Genet       Date:  2022-01-29       Impact factor: 3.412

2.  A rare homozygous missense mutation of COL7A1 in a Vietnamese family.

Authors:  Nguyen Thuy Duong; Luong Thi Lan Anh; Nguyen Huu Sau; Nguyen Bao Anh; Noriko Miyake; Nong Van Hai; Naomichi Matsumoto
Journal:  Hum Genome Var       Date:  2022-05-17

3.  High frequency of exon 15 deletion in the FANCA gene in Tunisian patients affected with Fanconi anemia disease: implication for diagnosis.

Authors:  Ahlem Amouri; Faten Talmoudi; Olfa Messaoud; Catherine D d'Enghien; Mariem B Rekaya; Ines Allegui; Héla Azaiez; Rym Kefi; Ahlem Abdelhak; Sondes H Meseddi; Lamia Torjemane; Monia Ouederni; Fethi Mellouli; Héla B Abid; Lamia Aissaoui; Mohamed Bejaoui; Tarek B Othmen; Dominique S Lyonnet; Jean Soulier; Mongia Hachicha; Koussay Dellagi; Sonia Abdelhak; Tunisian Fanconi
Journal:  Mol Genet Genomic Med       Date:  2014-02-05       Impact factor: 2.183

4.  Clinical practice guidelines for laboratory diagnosis of epidermolysis bullosa.

Authors:  C Has; L Liu; M C Bolling; A V Charlesworth; M El Hachem; M J Escámez; I Fuentes; S Büchel; R Hiremagalore; G Pohla-Gubo; P C van den Akker; K Wertheim-Tysarowska; G Zambruno
Journal:  Br J Dermatol       Date:  2019-08-09       Impact factor: 9.302

5.  Signatures of Dermal Fibroblasts from RDEB Pediatric Patients.

Authors:  Arkadii K Beilin; Nadezhda A Evtushenko; Daniil K Lukyanov; Nikolay N Murashkin; Eduard T Ambarchian; Alexander A Pushkov; Kirill V Savostyanov; Andrey P Fisenko; Olga S Rogovaya; Andrey V Vasiliev; Ekaterina A Vorotelyak; Nadya G Gurskaya
Journal:  Int J Mol Sci       Date:  2021-02-11       Impact factor: 5.923

Review 6.  Therapeutic Prospects of Exon Skipping for Epidermolysis Bullosa.

Authors:  Franciscus C Vermeer; Jeroen Bremer; Robert J Sietsma; Aileen Sandilands; Robyn P Hickerson; Marieke C Bolling; Anna M G Pasmooij; Henny H Lemmink; Morris A Swertz; Nine V A M Knoers; K Joeri van der Velde; Peter C van den Akker
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

7.  Whole exome sequencing identified a novel compound heterozygous variation in COL7A1 gene causing dystrophic epidermolysis bullosa.

Authors:  Li-Min Cui; Jian-Ye Jiang; Ning-Ning Hu; Hong-En Zou; Bao-Zhen Zhao; Cong-Ying Han; Kai Yang; Yi-Peng Wang; Huan-Xia Xing
Journal:  Mol Genet Genomic Med       Date:  2022-02-28       Impact factor: 2.473

8.  Case Report: Diagnostic and Therapeutic Challenges in Severe Mechanobullous Epidermolysis Bullosa Acquisita.

Authors:  Franziska Schauer; Alexander Nyström; Manfred Kunz; Stefanie Hübner; Sarah Scholl; Ioannis Athanasiou; Svenja Alter; Judith Fischer; Cristina Has; Dimitra Kiritsi
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

9.  Founder mutations in Tunisia: implications for diagnosis in North Africa and Middle East.

Authors:  Lilia Romdhane; Rym Kefi; Hela Azaiez; Nizar Ben Halim; Koussay Dellagi; Sonia Abdelhak
Journal:  Orphanet J Rare Dis       Date:  2012-08-21       Impact factor: 4.123

10.  Two novel mutations on exon 8 and intron 65 of COL7A1 gene in two Chinese brothers result in recessive dystrophic epidermolysis bullosa.

Authors:  Ying Lin; Xue-Jun Chen; Wei Liu; Bo Gong; Jun Xie; Jun-Hao Xiong; Jing Cheng; Xi-Ling Duan; Zhao-Chun Lin; Lu-Lin Huang; Hui-Ying Wan; Xiao-Qi Liu; Lin-Hong Song; Zheng-Lin Yang
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.